Invesco’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-277,124
| Closed | -$4.09M | – | 4022 |
|
|
2024
Q1 | $4.09M | Buy |
277,124
+265,058
| +2,197% | +$3.91M | ﹤0.01% | 2351 |
|
|
2023
Q4 | $162K | Buy |
+12,066
| New | +$162K | ﹤0.01% | 3593 |
|
|
2023
Q2 | – | Sell |
-210,507
| Closed | -$2.59M | – | 4030 |
|
|
2023
Q1 | $2.59M | Buy |
+210,507
| New | +$2.59M | ﹤0.01% | 2530 |
|
|
2020
Q1 | – | Sell |
-50,683
| Closed | -$160K | – | 3767 |
|
|
2019
Q4 | $160K | Sell |
50,683
-3,344
| -6% | -$10.6K | ﹤0.01% | 3507 |
|
|
2019
Q3 | $243K | Sell |
54,027
-17,326
| -24% | -$77.9K | ﹤0.01% | 3448 |
|
|
2019
Q2 | $340K | Sell |
71,353
-2,460
| -3% | -$11.7K | ﹤0.01% | 3423 |
|
|
2019
Q1 | $404K | Buy |
+73,813
| New | +$404K | ﹤0.01% | 3364 |
|
|
2015
Q3 | – | Sell |
-30,861
| Closed | -$3M | – | 4162 |
|
|
2015
Q2 | $3M | Sell |
30,861
-19,281
| -38% | -$1.88M | ﹤0.01% | 2358 |
|
|
2015
Q1 | $4.69M | Buy |
50,142
+8,845
| +21% | +$827K | ﹤0.01% | 2014 |
|
|
2014
Q4 | $3.67M | Buy |
41,297
+15,696
| +61% | +$1.4M | ﹤0.01% | 2115 |
|
|
2014
Q3 | $1.77M | Sell |
25,601
-24,252
| -49% | -$1.68M | ﹤0.01% | 2607 |
|
|
2014
Q2 | $2.86M | Buy |
+49,853
| New | +$2.86M | ﹤0.01% | 2355 |
|
|
2014
Q1 | – | Sell |
-763
| Closed | -$32K | – | 4388 |
|
|
2013
Q4 | $32K | Hold |
763
| – | – | ﹤0.01% | 4121 |
|
|
2013
Q3 | $23K | Sell |
763
-7,095
| -90% | -$214K | ﹤0.01% | 4146 |
|
|
2013
Q2 | $416K | Buy |
+7,858
| New | +$416K | ﹤0.01% | 3364 |
|